Form D · Biotechnology

Analytica Biosciences Corp.

Naples, FL · CIK 0001993415

Offering snapshot reported Sep 19, 2023 · SEC filing

Reported sold
$10K
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$2K
Reported outside-investor minimum
First sale
Sep 12, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5K$10KSep 13, 2023: $10,000.00Sep 13, 2023Sep 19, 2023: $10,000.00Sep 19, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 19, 2023Amendment$10,000$0vs Sep 13, 20231SEC filing
Sep 13, 2023Initial$10,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-491976

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Sep 19, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Asuna Pierpoint Gilfoyle Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6305 Naples Boulevard Suite 1280
Naples, FL, 34109